Understood. I was surprised at how low of doses they were using. I also don't expect Nektar to go to a triple study anytime soon though its interesting their initial collaboration is with BMS that has both.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.